Brief: Chromadex Believes U.S. Court Of Appeals Decision Reg 807 Dartmouth Patent
21/02/2023 13:54
Feb 21 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX CORP - BELIEVE U.S. COURT OF APPEALS DECISION
REGARDING 807 DARTMOUTH PATENT HAS NO MATERIAL IMPACT ON NR
BUSINESS
Source text for Eikon: ID:nBw4Qp8sCa
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce